InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Wei Lin, Directeur Médical. Insider active across 3 companies, notably Erasca, Inc.. Cumulatively, 12 filings have been recorded. Split: 0 buy · 4 sells. Total volume traded: €532k. Activity tracked since 1 February 2022. The latest transaction was filed on 17 March 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Wei Lin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
12 条申报中的 12 条
About Wei Lin
Wei Lin is Chief Medical Officer and appears in 12 filings. Across the 12 sampled filings, the transactions are sales for EUR 532181, with the modal transaction nature listed as Attribution, between 2022-02-03 and 2026-03-19, mainly at Revolution Medicines, Inc. and Erasca, Inc.
